Measles-containing-vaccine second-dose (MCV2) immunization coverage in Nicaragua
Nicaragua: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 95.0% in 2025. ◆ Volatile
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Nicaragua, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Nicaragua recorded 95.0% for measles-containing-vaccine second-dose (mcv2) immunization coverage in 2025.
Compared with earlier readings it is down 3.1% on the previous year and down 4.0% over five years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Nicaragua peaked at 99.0% in 2019 and was at its lowest, 0.0%, in 2000.
That places Nicaragua 29th out of 194 countries with data for 2025, putting it in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Nicaragua, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 0.0% | — |
| 2016 | 0.0% | — |
| 2017 | 84.0% | — |
| 2018 | 95.0% | +13.1% |
| 2019 | 99.0% | +4.2% |
| 2020 | 99.0% | +0.0% |
| 2021 | 86.0% | -13.1% |
| 2022 | 99.0% | +15.1% |
| 2023 | 98.0% | -1.0% |
| 2024 | 98.0% | +0.0% |
| 2025 | 95.0% | -3.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 10 |
| 2010s | 27.8% | 0.0% | 99.0% | 10 |
| 2020s | 95.8% | 86.0% | 99.0% | 6 |
Countries ranked near Nicaragua
- 26 Trinidad and Tobago 96.0% compare
- 26 Andorra 96.0% compare
- 26 Egypt 96.0% compare
- 29 India 95.0% compare
- 29 Uruguay 95.0% compare
- 29 Norway 95.0% compare
- 29 Mongolia 95.0% compare
- 29 Japan 95.0% compare
- 29 Viet Nam 95.0% compare
- 29 Republic of Korea 95.0% compare
- 29 Portugal 95.0% compare
- 29 Russian Federation 95.0% compare
- 29 Armenia 95.0% compare
- 29 Tuvalu 95.0% compare
- 29 Sri Lanka 95.0% compare
- 29 United States of America 95.0% compare
More health data for Nicaragua
- Un projection of annual infant deaths, annual growth rate -1.83 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6599 % change on previous year (2090)
- Heat deaths vs projected death rates 1,175 (2090)
- Un projection of annual infant deaths 215 (2100)
- Population ages 15-64, male, annual growth rate 1.83 % change on previous year (2025)
- Population ages 15-64, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 15-64, male, per capita 0.3246 units per person (2025)
- Population ages 15-64, total, annual growth rate 1.76 % change on previous year (2025)
- Population ages 15-64, total, per unit of GDP 0.0002 units per US$ of GDP (2025)
- Population ages 15-64, total, per capita 0.6599 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Nicaragua?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Nicaragua was 95.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Nicaragua?
- The highest recorded value was 99.0% in 2019.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Nicaragua?
- The lowest recorded value was 0.0% in 2000.
- How does Nicaragua rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Nicaragua ranks 29th out of 194 countries with data for 2025.
- Where does this Nicaragua data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).